Allogeneic hematopoietic stem cell transplantation: A single-center experience, 2017 to 2021

CONCLUSION: Donor type and donor age significantly impacted HSCT outcomes in our analysis, thus emphasizing the importance of rigorous donor selection in risk stratification and suggesting potential benefits for younger donors.PMID:38199270 | DOI:10.1016/j.trim.2024.101989

Source: Transplant Immunology - January 10, 2024 Category: Transplant Surgery Authors: Patr ícia Cristina Lopes da Silva Guilherme Campos Muzzi Maressa Ribeiro Vilela Raquel A Fabreti-Oliveira Source Type: research